<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01682109</url>
  </required_header>
  <id_info>
    <org_study_id>UMCN-AKF 11.05</org_study_id>
    <nct_id>NCT01682109</nct_id>
  </id_info>
  <brief_title>Palatability Testing of a New Paediatric Formulation of Valacyclovir</brief_title>
  <acronym>VALID-0</acronym>
  <official_title>Palatability Testing of a New Paediatric Formulation of Valacyclovir for the Prophylaxis and Treatment of VZV and HSV Infections in Children</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Radboud University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>ZonMw: The Netherlands Organisation for Health Research and Development</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Radboud University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Palatability testing of a new paediatric formulation of valacyclovir in children 4-12 years
      of age and at least one of their parents. Children will be included, who received
      (val)acyclovir prophylaxis in the past, or will probably need it in the future i.e. children
      with primary immune deficiency or cancer.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2012</start_date>
  <completion_date type="Actual">March 2016</completion_date>
  <primary_completion_date type="Actual">March 2016</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Selection of oral solution with best taste</measure>
    <time_frame>Day 1</time_frame>
    <description>Patients (children) will assess the taste of 3 different oral solutions. A questionnaire has to be completed to order the palatability of the three formulations.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Taste assessment</measure>
    <time_frame>Day 1</time_frame>
    <description>Children will score the taste of 3 different oral valacyclovir solutions. A 100 mm facial hedonic scale will be employed to indicate the palatability of each formulation.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Predictability of palatability preference of the child by parents.</measure>
    <time_frame>Day 1</time_frame>
    <description>To determine whether parents can predict the palatability preference of their child.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">41</enrollment>
  <condition>Varicella Zoster Virus Infection</condition>
  <condition>Herpes Simplex Virus Infection</condition>
  <arm_group>
    <arm_group_label>new paediatric valacyclovir formulation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Newly developed formulation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>reference valacyclovir formulation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Formulation derived from FDA label information</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Valacyclovir</intervention_name>
    <arm_group_label>new paediatric valacyclovir formulation</arm_group_label>
    <arm_group_label>reference valacyclovir formulation</arm_group_label>
    <other_name>valacyclovir solution</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subject is at least 4 years of age.

          -  Subject weighs at least 15kg.

          -  Subject is capable of performing the taste assessment, according to the investigator's
             judgement.

          -  The child and parent(s) are willing to participate in the taste assessment.

          -  Signed informed consent by the legal guardian for participation of the child and if
             the parent also wants to participate: signed informed consent for their own
             participation, prior to start of the study.

        Exclusion Criteria:

          -  Documented history of sensitivity/idiosyncrasy to medicinal products or excipients.

          -  Presence of any condition that influences taste sensation (such as upper respiratory
             infection, febrile illness within 3 days before the first dose, mucositis or use of
             medication that influences taste perception, as described in the label information).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>4 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>David Burger</last_name>
    <role>Principal Investigator</role>
    <affiliation>Radboud University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Radboud University Medical Center</name>
      <address>
        <city>Nijmegen</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>January 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 5, 2012</study_first_submitted>
  <study_first_submitted_qc>September 7, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 10, 2012</study_first_posted>
  <last_update_submitted>May 24, 2016</last_update_submitted>
  <last_update_submitted_qc>May 24, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 25, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>prophylaxis</keyword>
  <keyword>herpes zoster</keyword>
  <keyword>herpes simplex</keyword>
  <keyword>valacyclovir</keyword>
  <keyword>palatability</keyword>
  <keyword>paediatric</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infection</mesh_term>
    <mesh_term>Communicable Diseases</mesh_term>
    <mesh_term>Virus Diseases</mesh_term>
    <mesh_term>Herpes Simplex</mesh_term>
    <mesh_term>Herpes Zoster</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Valacyclovir</mesh_term>
    <mesh_term>Acyclovir</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

